FDA sets June date for latest review of Merck’s last-ditch antibiotic

FDA sets June date for latest review of Merck’s last-ditch antibiotic

Submitted by admin on February 4, 2020 - 10:01am
Source: 
Pharmaforum
News Tags: 
Merck
Recarbrio
FDA
antibiotic
HABP/VABP
Headline: 
FDA sets June date for latest review of Merck’s last-ditch antibiotic
snippet: 

The FDA has started a six-month priority review of Merck & Co/MSD’s triple antibiotic Recarbrio in a new indication, setting up a possible approval by 4 June.

Do Not Allow Advertisers to Use My Personal information